Market Overview:
The global Lyme disease diagnostics market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of Lyme disease, technological advancements in diagnostic tests, and growing awareness about Lyme disease. The serological tests segment is expected to dominate the global Lyme disease diagnostics market during the forecast period. This can be attributed to the high accuracy and reliability of these tests. The urine antigen tests segment is projected to grow at a higher CAGR than other segments during the forecast period owing to its ease of use and low cost as compared with other diagnostic methods. In terms of application, hospitals are expected to account for the largest share of the global Lyme disease diagnostics market duringthe forecast period.
Product Definition:
Lyme disease is a bacterial infection that is spread through the bites of infected ticks. Lyme disease diagnostics are tests used to detect the presence of bacteria that cause Lyme disease. These tests can be used to diagnose Lyme disease in people who have symptoms, as well as to screen people who may have been exposed to ticks. The importance of Lyme disease diagnostics is that they can help identify and treat the infection early, which may improve outcomes.
Serological Tests:
A serological test is a medical procedure to detect antibodies in the blood. Antibodies are proteins that are produced by the body in response to an injury or infection. The presence of these antibodies can indicate past infections as well as current ones. Serological tests are used for diagnosis of diseases such as lupus, rheumatoid arthritis, HIV, and Lyme disease among others.
Urine Antigen Tests:
Urine antigen tests are used for the detection of antibodies in the blood. These tests can also be used to detect other diseases like kidney infections, diabetes, and multiple sclerosis. The test works by detecting a certain chemical substance known as antigens that is released into the urine when a person is infected with Lyme disease bacteria.
Application Insights:
The others application segment dominated the market in terms of revenue share in 2017. This is due to the growing incidence of chronic Lyme disease and increasing government initiatives to raise awareness about this condition. For instance, according to a blog by Lyme Disease Association of America, chronic Lyme disease is estimated to affect around 30% - 40% of people with erythema migrans or other signs and symptoms consistent with early disseminated infection (EDI). Thus, rising prevalence coupled with increasing awareness about diagnostics for late-stage LD is expected to drive demand over the forecast period.
However, hospitals are expected register the highest CAGR during the forecast period owing to an increase in patient admissions for late-stage LD caused by tick bites across North America and Europe. In addition, an increase in R&D activities pertaining from public & private institutions along with biopharmaceutical companies focusing on development of advanced diagnostic tests will boost industry growth over next seven years.
Regional Analysis:
North America dominated the market in 2017. The presence of a large number of Lyme disease patients and high awareness levels coupled with the availability of advanced diagnostic tools are some factors attributing to its largest share. Moreover, increasing government initiatives for raising awareness regarding tick-borne diseases is also expected to drive regional growth over the forecast period.
The Asia Pacific market is anticipated to grow at a lucrative rate during the forecast period owing to an increase in healthcare expenditure by governments as well as private organizations and rising prevalence of infectious diseases such as malaria, dengue, chikungunya & Zika virus infections which are responsible for significant morbidity & mortality rates across this region.
Growth Factors:
- Increasing incidence of Lyme disease: The global incidence of Lyme disease is increasing due to the expanding geographical range of the tick vector and rising human population. According to a study by Centers for Disease Control and Prevention (CDC), the number of people diagnosed with Lyme disease in United States has increased from about 10,000 cases in 1991 to more than 30,000 cases in 2013. This is expected to drive the demand for Lyme disease diagnostics market over the forecast period.
- Growing awareness about early diagnosis and treatment: There is growing awareness among people about early diagnosis and treatment of Lyme disease, which is expected to boost demand for diagnostic tests over the forecast period. In addition, increasing funding by government organizations for research on new diagnostic tests will also propel growth of this market during forecast period.
- Technological advancements: The development of novel technologies such as polymerase chain reaction (PCR) assay has revolutionized detection process for lyme diseases and this is anticipated to fuel growth prospects for this market during next few years . In addition, introduction o new point-of-care testing devices will also provide impetus growth prospects fo lyme diagnostics market during next few years .
Scope Of The Report
Report Attributes
Report Details
Report Title
Lyme Disease Diagnostics Market Research Report
By Type
Serological Tests, Urine Antigen Tests, Lymphocytic Transformation Tests, Immunofluorescent Staining, Nucleic Acid Tests
By Application
Hospitals, Clinics, Others
By Companies
Abbott Laboratories, Abbott, Bio-Rad, Canon Life Sciences, Global Lyme Diagnostics, Graphene Frontiers, Oxford Immunotec, Trinity Biotech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Lyme Disease Diagnostics Market Report Segments:
The global Lyme Disease Diagnostics market is segmented on the basis of:
Types
Serological Tests, Urine Antigen Tests, Lymphocytic Transformation Tests, Immunofluorescent Staining, Nucleic Acid Tests
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Abbott
- Bio-Rad
- Canon Life Sciences
- Global Lyme Diagnostics
- Graphene Frontiers
- Oxford Immunotec
- Trinity Biotech
Highlights of The Lyme Disease Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Serological Tests
- Urine Antigen Tests
- Lymphocytic Transformation Tests
- Immunofluorescent Staining
- Nucleic Acid Tests
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lyme Disease Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Lyme disease diagnostics is a term that refers to the various tests and procedures used to diagnose Lyme disease. These tests can help determine if someone has Lyme disease, as well as identify any potential complications that may be associated with the infection.
Some of the major players in the lyme disease diagnostics market are Abbott Laboratories, Abbott, Bio-Rad, Canon Life Sciences, Global Lyme Diagnostics, Graphene Frontiers, Oxford Immunotec, Trinity Biotech.
The lyme disease diagnostics market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Lyme Disease Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Lyme Disease Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Lyme Disease Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Lyme Disease Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Lyme Disease Diagnostics Market Size & Forecast, 2018-2028
4.5.1 Lyme Disease Diagnostics Market Size and Y-o-Y Growth
4.5.2 Lyme Disease Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Lyme Disease Diagnostics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Lyme Disease Diagnostics Market Size Forecast by Type
5.2.1 Serological Tests
5.2.2 Urine Antigen Tests
5.2.3 Lymphocytic Transformation Tests
5.2.4 Immunofluorescent Staining
5.2.5 Nucleic Acid Tests
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Lyme Disease Diagnostics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Lyme Disease Diagnostics Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Lyme Disease Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Lyme Disease Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Lyme Disease Diagnostics Analysis and Forecast
9.1 Introduction
9.2 North America Lyme Disease Diagnostics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Lyme Disease Diagnostics Market Size Forecast by Type
9.6.1 Serological Tests
9.6.2 Urine Antigen Tests
9.6.3 Lymphocytic Transformation Tests
9.6.4 Immunofluorescent Staining
9.6.5 Nucleic Acid Tests
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Lyme Disease Diagnostics Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Lyme Disease Diagnostics Analysis and Forecast
10.1 Introduction
10.2 Europe Lyme Disease Diagnostics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Lyme Disease Diagnostics Market Size Forecast by Type
10.6.1 Serological Tests
10.6.2 Urine Antigen Tests
10.6.3 Lymphocytic Transformation Tests
10.6.4 Immunofluorescent Staining
10.6.5 Nucleic Acid Tests
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Lyme Disease Diagnostics Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Lyme Disease Diagnostics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Lyme Disease Diagnostics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Lyme Disease Diagnostics Market Size Forecast by Type
11.6.1 Serological Tests
11.6.2 Urine Antigen Tests
11.6.3 Lymphocytic Transformation Tests
11.6.4 Immunofluorescent Staining
11.6.5 Nucleic Acid Tests
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Lyme Disease Diagnostics Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Lyme Disease Diagnostics Analysis and Forecast
12.1 Introduction
12.2 Latin America Lyme Disease Diagnostics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Lyme Disease Diagnostics Market Size Forecast by Type
12.6.1 Serological Tests
12.6.2 Urine Antigen Tests
12.6.3 Lymphocytic Transformation Tests
12.6.4 Immunofluorescent Staining
12.6.5 Nucleic Acid Tests
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Lyme Disease Diagnostics Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Lyme Disease Diagnostics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Lyme Disease Diagnostics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Lyme Disease Diagnostics Market Size Forecast by Type
13.6.1 Serological Tests
13.6.2 Urine Antigen Tests
13.6.3 Lymphocytic Transformation Tests
13.6.4 Immunofluorescent Staining
13.6.5 Nucleic Acid Tests
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Lyme Disease Diagnostics Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Lyme Disease Diagnostics Market: Competitive Dashboard
14.2 Global Lyme Disease Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Abbott
14.3.3 Bio-Rad
14.3.4 Canon Life Sciences
14.3.5 Global Lyme Diagnostics
14.3.6 Graphene Frontiers
14.3.7 Oxford Immunotec
14.3.8 Trinity Biotech
